Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart patch keeps watch after surgery — could it save lives by catching trouble early?

NCT ID NCT07729891

Knowledge-focused Sponsor: Azienda Ospedaliero-Universitaria di Parma Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This study tests whether a wearable chest patch that continuously tracks heart rate, breathing, and blood oxygen can detect complications earlier than routine nurse checks in adults recovering from major urologic surgery. Participants wear the device for three days after surgery, and hospital staff receive alerts if vital signs stray from normal. The goal is to see if earlier warnings help prevent serious deterioration and unplanned intensive care stays.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a wearable chest patch that continuously tracks heart rate, breathing rate, and blood oxygen levels
What this could lead to
If it works, this could help hospitals catch postoperative complications earlier, potentially reducing the need for intensive care and improving patient safety.
What could go wrong
This is an observational study, not a randomized trial, so it cannot prove cause and effect. The device may also trigger false alarms, leading to unnecessary interventions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients undergoing to major urological surgery performed under general anesthesia and without a planned intensive care unit admission.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Ability to give informed consent and consent to the processing of personal data by signing the relevant forms; * Aged over 18 years old * Medium-to-high complexity urological surgery without the need for post-operative monitoring in the Intensive Care Unit * Surgery performed under general anaesthesia * Discharge to the ward is scheduled upon leaving the operating theatre Exclusion Criteria: * Refusal or inability to consent to participation * Patients under 18 years old * Planned admission to Post-Operative Intensive Care Unit after the surgery * Unplanned admission to the Post-Operative Intensive Care Unit at the end of the surgery * Anaesthetic technique other than general anaesthesia.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac complications are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Postoperative Complications

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac complications Postoperative complication Respiratory complications

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • 2^ Anestesia, Rianimazione, Terapia Intensiva - Azienda Ospedaliero Universitaria di Parma

    RECRUITING

    Parma, Parma, 43126, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.